That's a wild P/E estimate. How do you get that?
Current projected earnings are going to be around $85 to $90mil AUD this year after these disappointing results.
Shares on issue 127mil. That gives EPS of about 71 cents. P/E on $17 is 24.
Their earnings are expected to decline on these results over the next 12 months, at best flat. Some serious revisions will be coming.
Given they can't point to any reason for their earnigns to grow, I can't see why the share price doesn't fall by at least 30% to reflect this risk. Angelman is the only thing that could save them at this point.
Seems like the short report was bang on the money, there is very limited to no growth in daybue. Looks like a total dud.
- Forums
- ASX - By Stock
- NEU
- Ann: Q2 2024 update
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.80%
!
$12.54

Ann: Q2 2024 update, page-18
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.54 |
Change
0.100(0.80%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.44 | $12.73 | $12.13 | $11.07M | 885.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1215 | $12.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.54 | 804 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 12.480 |
1 | 796 | 12.300 |
1 | 400 | 12.240 |
1 | 3000 | 12.230 |
1 | 761 | 12.210 |
Price($) | Vol. | No. |
---|---|---|
12.600 | 1020 | 1 |
12.710 | 628 | 2 |
12.720 | 1982 | 1 |
12.820 | 3050 | 1 |
12.900 | 5012 | 1 |
Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |